Search

Saved articles

You have not yet added any article to your bookmarks!

Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

TrumpRx.gov: A Comprehensive Update with 600 New Generic Medicines

TrumpRx.gov: A Comprehensive Update with 600 New Generic Medicines

Post by : Shweta

President Donald Trump has officially revealed a significant enhancement to TrumpRx.gov, a government-hosted resource aimed at assisting Americans in locating lower prices on prescription medications. This expansion introduces an additional 600 generic drugs to the site, allowing individuals to make informed comparisons and secure savings on essential healthcare products. The announcement was made during a White House event focused on the pressing need to reduce medicine costs across the nation.

The administration emphasized that this upgraded version of TrumpRx.gov is intended to foster greater transparency within the U.S. healthcare landscape. Users can now explore medications online, compare rates at nearby pharmacies, and assess home delivery alternatives from a range of pharmacy partners. The platform features discounts and pricing details from prominent companies including Amazon Pharmacy, GoodRx, and Cost Plus Drugs. The objective is to empower Americans by providing a clear view of actual cash prices for medications, beyond just relying on insurance plans or intermediaries.

The newly included medications predominantly encompass widely-used generic prescriptions that cater to the needs of millions of Americans daily. Examples include drugs for diabetes, hypertension, cholesterol management, and heart health, such as atorvastatin, metformin, lisinopril, and clopidogrel. The White House noted that generic medications constitute over 90% of the prescriptions dispensed in the U.S., marking this enhancement as a pivotal development for patients seeking affordable health solutions.

The Trump administration highlighted the platform's usefulness for individuals who self-pay for their prescriptions or have high deductible insurance plans. By enabling users to compare pharmacy prices in a centralized location, they might discover lower-cost alternatives that can be more economical than standard insurance co-payments. Officials are optimistic that this initiative will spur competition among pharmacy discount services, potentially driving prices further down.

Initially launched in early 2026 with approximately 40 branded medicines tied to the administration’s “Most-Favored-Nation” drug pricing guideline, TrumpRx.gov aims to align U.S. medicine prices with those in other developed nations. Since its inception, new collaborations with pharmaceutical producers and pharmacy discount organizations have been continually established. This latest expansion stands out as one of the program's most notable upgrades.

President Trump stated that the revamped website could support Americans in finding “the lowest feasible costs” for their prescriptions. The administration also claims the platform has garnered millions of visits thus far and has significantly aided consumers in reducing their healthcare expenses. During the announcement event, officials underscored the lowered prices on several popular medications, particularly those treating diabetes and obesity.

Nonetheless, this expansion has faced pushback from some healthcare professionals and policy analysts. Critics point out that many Americans already enjoy enhanced pricing through their health insurance plans, with some discounts featured on TrumpRx.gov previously available through other avenues. Additionally, doubts have been raised regarding whether this program truly addresses the overarching challenge of escalating healthcare expenses in the United States.

In spite of the criticisms, the Trump administration remains confident that the broadened TrumpRx.gov platform will foster increased competition in the pharmaceutical sector, granting Americans greater agency in how they procure medications. The White House views this move as a crucial part of an extensive initiative to lower prescription drug prices, enhance transparency, and alleviate the financial strain faced by American families managing healthcare costs.

May 19, 2026 10:10 a.m. 599

#world news #US News #GlobalNews

Singapore Reviews New US Chip Export Controls Targeting China
Nov. 17, 2026 11:34 a.m.
Singapore reviews US chip export restrictions targeting China's AI access, raising concerns for semiconductor trade and data centre businesses
Read More
APEC Members Emphasise Safe and Responsible Use of Artificial Intelligence
Nov. 17, 2026 10:24 a.m.
APEC members discuss responsible AI use, digital innovation and data governance as China and the US compete for global AI leadership
Read More
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
Nov. 16, 2026 5:18 p.m.
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governance rights and decision-making powers
Read More
US Dollar Extends Rally as Yen Faces Pressure After Weak GDP
Nov. 16, 2026 4:29 p.m.
The US dollar reaches a 19-month high as traders assess Fed rate signals, weak Japan GDP data and possible yen intervention
Read More
Sheikh Hasina Plans December Return to Bangladesh Despite Death Threat
Nov. 16, 2026 3:35 p.m.
Sheikh Hasina plans to return to Bangladesh in December despite death threats, a death sentence and growing political tensions with Dhaka
Read More
Trump Plans to Name Nvidia and AI Firms US National Champions
Nov. 16, 2026 10:01 a.m.
Trump administration plans to name Nvidia, Amazon, Microsoft and OpenAI among US AI national champions to expand overseas and compete with China
Read More
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Nov. 7, 2026 11:10 a.m.
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing white-ball cricket and domestic matches
Read More
Najib Razak Leaves Prison to Serve Remaining Sentence at Home
Nov. 6, 2026 2:22 p.m.
Najib Razak leaves Kajang Prison after payment of a RM50 million fine, allowing Malaysia's former PM to serve his remaining sentence at home
Read More
Singapore Warns Users About Privacy and Security Risks of AI Agents
Nov. 6, 2026 12:50 p.m.
Singapore warns users about AI agent security risks, data privacy, online scams and unauthorised access to personal accounts
Read More
Trending News